Cargando…

Prevalence and Impact on Mortality of Colonization and Super-Infection by Carbapenem-Resistant Gram-Negative Organisms in COVID-19 Hospitalized Patients

Background: The relationship between superinfection by multidrug-resistant Gram-negative bacteria and mortality among SARS-CoV-2 hospitalized patients is still unclear. Carbapenem-resistant Acinetobacter baumannii and carbapenemase-producing Enterobacterales are among the most frequently isolated sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casale, Roberto, Bianco, Gabriele, Bastos, Paulo, Comini, Sara, Corcione, Silvia, Boattini, Matteo, Cavallo, Rossana, Rosa, Francesco Giuseppe De, Costa, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534345/ https://www.ncbi.nlm.nih.gov/pubmed/37766340 http://dx.doi.org/10.3390/v15091934

Ejemplares similares

Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms
por: Bianco, Gabriele, et al.
Publicado: (2022)

Impact of NG-Test CTX-M MULTI Immunochromatographic Assay on Antimicrobial Management of Escherichia coli Bloodstream Infections
por: Boattini, Matteo, et al.
Publicado: (2023)

MALDI-TOF MS-Based Approaches for Direct Identification of Gram-Negative Bacteria and Bla(KPC)-Carrying Plasmid Detection from Blood Cultures: A Three-Year Single-Centre Study and Proposal of a Diagnostic Algorithm
por: Bianco, Gabriele, et al.
Publicado: (2022)

Occurrence of multi-carbapenemases producers among carbapenemase-producing Enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 era
por: Bianco, Gabriele, et al.
Publicado: (2022)

Implementation of Chromatic Super CAZ/AVI(®) medium for active surveillance of ceftazidime-avibactam resistance: preventing the loop from becoming a spiral
por: Bianco, Gabriele, et al.
Publicado: (2022)

Direct detection of extended-spectrum-β-lactamase-producers in Enterobacterales from blood cultures: a comparative analysis
por: Boattini, Matteo, et al.
Publicado: (2021)

Disc Diffusion and ComASP(®) Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory Routine
por: Bianco, Gabriele, et al.
Publicado: (2023)

Multicentre Evaluation of the EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) Extending Analysis to 16–20 Hours Reading Time
por: Bianco, Gabriele, et al.
Publicado: (2022)

Fast-track identification of CTX-M-extended-spectrum-β-lactamase- and carbapenemase-producing Enterobacterales in bloodstream infections: implications on the likelihood of deduction of antibiotic susceptibility in emergency and internal medicine departments
por: Boattini, Matteo, et al.
Publicado: (2021)

Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales
por: Vena, Antonio, et al.
Publicado: (2020)

Outbreak of ceftazidime-avibactam resistant Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in a COVID-19 intensive care unit, Italy: urgent need for updated diagnostic protocols of surveillance cultures
por: Bianco, G., et al.
Publicado: (2022)

Bloodstream Infections Caused by Carbapenem-Resistant Pathogens in Intensive Care Units: Risk Factors Analysis and Proposal of a Prognostic Score
por: Montrucchio, Giorgia, et al.
Publicado: (2022)

The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: “Attack on Titan”
por: Mancuso, Giuseppe, et al.
Publicado: (2023)

Clinical Impact of Colonization with Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Admitted for Severe Trauma
por: Ceccarelli, Giancarlo, et al.
Publicado: (2022)

Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
por: Nordmann, Patrice, et al.
Publicado: (2019)

Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
por: Jean, Shio-Shin, et al.
Publicado: (2022)

Comparison of Risk Factors and Outcomes in Carbapenem-Resistant and Carbapenem-Susceptible Gram-Negative Bacteremia
por: Cetin, Sinan, et al.
Publicado: (2021)

Effectiveness of a double-carbapenem combinations against carbapenem-resistant Gram-negative bacteria
por: Lu, Jiayue, et al.
Publicado: (2022)

Positive and Negative Ions Potently Inhibit the Viability of Airborne Gram-Positive and Gram-Negative Bacteria
por: Comini, Sara, et al.
Publicado: (2021)

Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection
por: Bianco, Gabriele, et al.
Publicado: (2021)

The role of carbapenems in initial therapy for serious Gram-negative infections
por: Rahal, James J
Publicado: (2008)

Optimizing the use of carbapenems in the face of increasing Gram-negative resistance
por: Ramphal, Reuben
Publicado: (2008)

Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens
por: Lee, Chang-Seop, et al.
Publicado: (2014)

Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
por: Doi, Yohei
Publicado: (2019)

Editorial: The global threat of carbapenem-resistant gram-negative bacteria
por: Dropa, Milena, et al.
Publicado: (2022)

Incidence of Carbapenem-Resistant Gram Negatives in Italian Transplant Recipients: A Nationwide Surveillance Study
por: Lanini, Simone, et al.
Publicado: (2015)

Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study
por: Pascale, Renato, et al.
Publicado: (2021)

Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience
por: Piccica, Matteo, et al.
Publicado: (2023)

Safety of a Carbapenem Restriction Policy in Patients with Gram-Negative Bacteremia
por: Mani, Nandita S, et al.
Publicado: (2017)

Risk Factors for Development of Carbapenem Resistance Among Gram-Negative Rods
por: Richter, Stefan E, et al.
Publicado: (2019)

Molecular epidemiology & therapeutic options of carbapenem-resistant Gram-negative bacteria
por: Garg, Atul, et al.
Publicado: (2019)

Attributable burden in patients with carbapenem-nonsusceptible gram-negative respiratory infections
por: Tabak, Ying P., et al.
Publicado: (2020)

The Place of Meropenem–Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections
por: Chopra, Teena
Publicado: (2021)

Emergence of Carbapenem-Resistant Gram-Negative Isolates in Hospital Settings in Djibouti
por: Ragueh, Ayan Ali, et al.
Publicado: (2023)

Performance Evaluation of BD Phoenix and MicroScan WalkAway Plus for Determination of Fosfomycin Susceptibility in Enterobacterales
por: Bondi, Alessandro, et al.
Publicado: (2023)

Rubella serosurvey and factors related to vaccine hesitancy in childbearing women in Italy
por: Boattini, Matteo, et al.
Publicado: (2019)

Evaluating the Efficacies of Carbapenem/β-Lactamase Inhibitors Against Carbapenem-Resistant Gram-Negative Bacteria in vitro and in vivo
por: El Hafi, Bassam, et al.
Publicado: (2019)

Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion
por: Coppola, Nicola, et al.
Publicado: (2022)

Drug Resistance and Molecular Epidemiology of Carbapenem Resistant Gram-negative Bacilli Isolates
por: Naim, Huma, et al.
Publicado: (2018)

Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria
por: Bourafa, Nadjette, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j128iba825rjm8evt1h3i0h9be